150. Marsh NL, Iwaoka WT, Mower HF:
Formation of mutagens during the frying of Hawaiian fish: correlation with creatine and creatinine content.
Mutat Res
1990,
242
(3):181-186.
151. Felton JS, Knize MG, Shen NH, Lewis PR, Andresen BD, Happe J, Hatch FT:
The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Carcinogenesis
1986,
7
(7):1081-1086.
152. Heterocyclic amines in cooked meats
http://www.cancer.gov/cancertopics/factsheet/Risk/heterocyclic-amines
153. Sugimura T:
Past, present, and future of mutagens in cooked foods.
Environ Health Perspect
1986,
67
:5-10.
154. Bjeldanes LF, Morris MM, Felton JS, Healy S, Stuermer D, Berry P, Timourian H, Hatch FT:
Mutagens from the cooking of food. III. Survey by Ames/Salmonella test of mutagen formation in secondary sources of cooked dietary protein.
Food Chem Toxicol
1982,
20
(4):365-369.
155. Chen BH, Lee KH, Tai CY:
Formation of heterocyclic amines in fried fish fiber during processing and storage.
J Food Prot
2000,
63
(10):1415-1420.
156. Nagao M, Ushijima T, Wakabayashi K, Ochiai M, Kushida H, Sugimura T, Hasegawa R, Shirai T, Ito N:
Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods.
Cancer
1994,
74
(3 Suppl):1063-1069.
157. Pariza MW, Loretz LJ, Storkson JM, Holland NC:
Mutagens and modulator of mutagenesis in fried ground beef.
Cancer Res
1983,
43
(5 Suppl):2444s-2446s.
158. Persson E, Sjoholm I, Nyman M, Skog K:
Addition of various carbohydrates to beef burgers affects the formation of heterocyclic amines during frying.
J Agric Food Chem
2004,
52
(25):7561-7566.
159. Skog K, Steineck G, Augustsson K, Jagerstad M:
Effect of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues.
Carcinogenesis
1995,
16
(4):861-867.
160. Aygun SF, Kabadayi F:
Determination of benzo[a]pyrene in charcoal grilled meat samples by HPLC with fluorescence detection.
Int J Food Sci Nutr
2005,
56
(8):581-585.
161. McDonald JD, Zielinska B, Fujita EM, Sagebiel JC, Chow JC, Watson JG:
Emissions from charbroiling and grilling of chicken and beef.
J Air Waste Manag Assoc
2003,
53
(2):185-194.
162. van Maanen JM, Moonen EJ, Maas LM, Kleinjans JC, van Schooten FJ:
Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat.
Carcinogenesis
1994,
15
(10):2263-2268.
163. Phillips DH:
Polycyclic aromatic hydrocarbons in the diet.
Mutat Res
1999,
443
(1-2):139-147.
164. Visciano P, Perugini M, Amorena M, Ianieri A:
Polycyclic aromatic hydrocarbons in fresh and cold-smoked Atlantic salmon fillets.
J Food Prot
2006,
69
(5):1134-1138.
165. Laser Reutersward A, Skog K, Jagerstad M:
Mutagenicity of pan-fried bovine tissues in relation to their content of creatine, creatinine, monosaccharides and free amino acids.
Food Chem Toxicol
1987,
25
(10):755-762.
166. Lin JY, Lee H, Huang HI:
Formation of mutagens in boiled pork extract.
Food Chem Toxicol
1982,
20
(5):531-533.
167. Tikkanen LM, Latva-Kala KJ, Heinio RL:
Effect of commercial marinades on the mutagenic activity, sensory quality and amount of heterocyclic amines in chicken grilled under different conditions.
Food Chem Toxicol
1996,
34
(8):725-730.
168. Curfs DM, Lutgens E, Gijbels MJ, Kockx MM, Daemen MJ, van Schooten FJ:
Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice.
Am J Pathol
2004,
164
(1):101-108.
169. Morales-Aizpurua IC, Tenuta-Filho A:
Oxidation of cholesterol in mayonnaise during storage.
Food Chemistry
2005,
89
(4):611-615.
170. Jensen MH, Nielsen TG, Dahllof I:
Effects of pyrene on grazing and reproduction of
Calanus finmarchicus
and
Calanus glacialis
from Disko Bay, West Greenland.
Aquat Toxicol
2008,
87
(2):99-107.
171. Saunders CR, Das SK, Ramesh A, Shockley DC, Mukherjee S:
Benzo[a]pyrene-induced acute neurotoxicity in the F-344 rat: role of oxidative stress.
J Appl Toxicol
2006,
26
(5):427-438.
172. Saunders CR, Ramesh A, Shockley DC:
Modulation of neurotoxic behavior in F-344 rats by temporal disposition of benzo[a]pyrene.
Toxicol Lett
2002,
129
(1-2):33-45.
173. Saunders CR, Shockley DC, Knuckles ME:
Behavioral effects induced by acute exposure to benzo[a]pyrene in F-344 rats.
Neurotox Res
2001,
3
(6):557-579.
174. Konstandi M, Harkitis P, Thermos K, Ogren SO, Johnson EO, Tzimas P, Marselos M:
Modification of inherent and drug-induced dopaminergic activity after exposure to benzo[a]pyrene.
Neurotoxicology
2007,
28
(4):860-867.
175. Stephanou P, Konstandi M, Pappas P, Marselos M:
Alterations in central monoaminergic neurotransmission induced by polycyclic aromatic hydrocarbons in rats.
Eur J Drug Metab Pharmacokinet
1998,
23
(4):475-481.
176. Grova N, Valley A, Turner JD, Morel A, Muller CP, Schroeder H:
Modulation of behavior and NMDA-R1 gene mRNA expression in adult female mice after sub-acute administration of benzo[a]pyrene.
Neurotoxicology
2007,
28
(3):630-636.
177. Nie J, Zhao J, Zhang H, Niu Q:
Effects of benro(a)pyrene on learning and memory and the content of monoamine neurotransmitters in rats.
Wei Sheng Yan Jiu
2008,
37
(5):517-520.
178. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G:
4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis.
Mol Nutr Food Res
2005,
49
(11):1044-1049.
179. Morin RJ, Peng SK:
The role of cholesterol oxidation products in the pathogenesis of atherosclerosis.
Ann Clin Lab Sci
1989,
19
(4):225-237.
180. Chang JY, Chavis JA, Liu LZ, Drew PD:
Cholesterol oxides induce programmed cell death in microglial cells.
Biochem Biophys Res Commun
1998,
249
(3):817-821.
181. Ostergren A, Fredriksson A, Brittebo EB:
Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.
J Neural Transm
2006,
113
(3):313-329.
182. Louis ED, Rios E, Pellegrino KM, Jiang W, Factor-Litvak P, Zheng W:
Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor.
Neurotoxicology
2008,
29
(3):460-465.
183. Rommelspacher H, Dufeu P, Schmidt LG:
Harman and norharman in alcoholism: correlations with psychopathology and long-term changes.
Alcohol Clin Exp Res
1996,
20
(1):3-8.
184. Mayersohn M, Conrad KA, Achari R:
The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance.
Br J Clin Pharmacol
1983,
15
(2):227-230.
185. Blake PG, Balaskas EV, Izatt S, Oreopoulos DG:
Is total creatinine clearance a good predictor of clinical outcomes in continuous ambulatory peritoneal dialysis?
Perit Dial Int
1992,
12
(4):353-358.
186. Chang WK, Hung KY, Huang JW, Wu KD, Tsai TJ:
Chronic fatigue in long-term peritoneal dialysis patients.
Am J Nephrol
2001,
21
(6):479-485.
187. Holley JL:
Patient-reported symptoms and adequacy of dialysis as measured by creatinine clearance.
Perit Dial Int
1993,
13
(Suppl 2):S219-S220.
188. Agren H, Niklasson F:
Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note.
J Neural Transm
1988,
74
(1):55-59.
189. Hedayati SS, Jiang W, O’Connor CM, Kuchibhatla M, Krishnan KR, Cuffe MS, Blazing MA, Szczech LA:
The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure.
Am J Kidney Dis
2004,
44
(2):207-215.
190. Kusleikaite N, Bumblyte IA, Pakalnyte R:
Quality of life and depression in renal transplant patients.
Medicina (Kaunas)
2007,
43
(Suppl 1):103-108.
191. Sacks CR, Peterson RA, Kimmel PL:
Perception of illness and depression in chronic renal disease.
Am J Kidney Dis
1990,
15
(1):31-39.
192. Bates CJ, Prentice A, Finch S:
Nutritional characteristics of people with impaired mental capacity from a nationally representative survey of British people aged 65 years and over.
J Nutr Health Aging
2004,
8
(4):240-244.
193. Corsonello A, Pedone C, Pahor M, Malara A, Carosella L, Mazzei B, Onder G, Corsonello F, Carbonin P, Corica F:
Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients.
Magnes Res
2001,
14
(4):273-282.
194. Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer A, Kuller LH:
Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study.
J Am Soc Nephrol
2004,
15
(7):1904-1911.
195. Kalaitzakis E, Bjornsson E:
Renal function and cognitive impairment in patients with liver cirrhosis.
Scand J Gastroenterol
2007,
42
(10):1238-1244.
196. Madan P, Agarwal S, Kalra OP, Tandon OP:
Effect of hemodialysis on cognitive function in ESRD patients.
Ren Fail
2007,
29
(6):699-703.
197. Hagiwara A, Asakawa E, Kurata Y, Sano M, Hirose M, Ito N:
Dose-dependent renal tubular toxicity of harman and norharman in male F344 rats.
Toxicol Pathol
1992,
20
(2):197-204.
198. Hagiwara A, Tanaka H, Kurata Y, Kato T, Tsuda H, Ito N:
Lack of hepatotoxicity or promotion of enzyme-altered liver foci development in rats treated with harman or norharman.
J Toxicol Environ Health
1990,
29
(2):211-218.
199. Ergene E, Schoener EP:
Effects of harmane (1-methyl-beta-carboline) on neurons in the
nucleus accumbens
of the rat.
Pharmacol Biochem Behav
1993,
44
(4):951-957.
200. Zetler G:
Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
Peptides
1982,
3
(4):701-704.
201. Bremer V, Bocter N, Rehmet S, Klein G, Breuer T, Ammon A:
Consumption, knowledge, and handling of raw meat: a representative cross-sectional survey in Germany, March 2001.
J Food Prot
2005,
68
(4):785-789.
202. Vangeel L, Houf K, Chiers K, Vercruysse J, D’Herde K, Ducatelle R:
Molecular-based identification of
Sarcocystis hominis
in Belgian minced beef.
J Food Prot
2007,
70
(6):1523-1526.
203. Fact sheets: Meat preparation, focus on sausages
http://www.fsis.usda.gov/Fact_Sheets/Sausage_and_Food_Safety/index.asp